Germany’s Bayer AG (ADR) (OTCMKTS:BAYRY) has agreed to buy Merck & Co.’s non-prescription medicine and consumer care business for $14.2 billion, gaining products such as Claritin allergy pills, Coppertone sun lotion and Dr. Scholl’s footcare products. On last trading day company shares ended up $141.20.
Teva Pharmaceutical Industries Ltd. (ADR) (NYSE:TEVA) lost a bid to block approval of a generic form of Copaxone, a multiple sclerosis drug that may account for half the company’s profit, 10 days before the patent on the medication expires. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) shares fell -1.31% in last trading session and ended the day on $50.53. TEVA gross Margin is 53.00% and its return on assets is 2.90%.Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) quarterly performance is 15.52%.
Novartis International AG (ADR) (NYSE:NVS) Novartis settles patent litigation on Gleevec® (imatinib mesylate) with Sun Pharma subsidiary. Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement. Novartis AG (ADR) (NYSE:NVS) shares moved up 0.87% in last trading session and was closed at $89.24, while trading in range of $89.05 – $89.52. Novartis AG (ADR) (NYSE:NVS) year to date (YTD) performance is 14.76%.
Johnson & Johnson’s (NYSE:JNJ) life science “innovation centre”, which opened a year ago, represents a different approach to drug development based on building networks and scouting for small deals, rather than mega-merger consolidation. Johnson & Johnson (NYSE:JNJ) ended the last trading day at $100.87. Company weekly volatility is calculated as 0.71% and price to cash ratio as 9.77.Johnson & Johnson (NYSE:JNJ) showed a negative weekly performance of -0.04%.
Chemical giant BASF SE (ADR) (OTCMKTS:BASFY) announced recently scholarship awards to three area students totaling $30,000. On last trading day company shares ended up $114.29.